Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial
about
Physical health care monitoring for people with serious mental illnessPhysical health care monitoring for people with serious mental illnessTargeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophreniaElectrophysiological intermediate biomarkers for oxidative stress in schizophreniaBehavioral assessment of acute inhibition of system xc (-) in ratsRedox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?Connexin43 hemichannel-mediated regulation of connexin43.N-acetyl cysteine and mushroom Agaricus sylvaticus supplementation decreased parasitaemia and pulmonary oxidative stress in a mice model of malaria.Antioxidants as potential therapeutics for neuropsychiatric disorders.Future perspectives on the treatment of cognitive deficits and negative symptoms in schizophrenia.Combining redox-proteomics and epigenomics to explain the involvement of oxidative stress in psychiatric disorders.Functional dysconnectivity in schizophrenia and its relationship to neural synchrony.Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries.Targeting of NMDA receptors in new treatments for schizophrenia.Development of novel therapy of schizophrenia in children and adolescents.The neurobiology and treatment of first-episode schizophrenia.Glutamatergic agents for schizophrenia: current evidence and perspectives.Cognitive effects of adjunctive N-acetyl cysteine in psychosis.Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats.Oxidative/Nitrosative stress in psychiatric disorders: are we there yet?Treatment and early intervention in psychosis program (TIPP-Lausanne): Implementation of an early intervention programme for psychosis in Switzerland.N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trialN-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence
P2860
Q24201094-AA3DED80-3587-4F5F-8428-FC60786EBD00Q24236698-7C5BD27C-E4EB-4A02-9B68-488E182BD98EQ30380519-D095A3EF-83E9-46A3-827B-75F51FB540CFQ30403518-863C0850-B838-4949-9C23-7504A7DC9D2BQ33647885-460970B9-3B64-4A28-B74D-B07FB8C64E35Q34420036-FB216A34-7C09-4345-9D9B-D69D7B2D5A11Q34428194-65752340-329E-4C63-8F61-3E963DA2A13AQ34608929-4DED2017-84F8-4FD6-9649-EC3C5D5EA3C1Q35619602-F1E3FC52-7F9A-4B2D-8389-1B93CE572455Q36736055-C1A9EE0F-6ACB-4FE3-9FBB-0D95DBF2F45CQ36930839-F23C14FE-84E8-45B2-9A8E-996A25EBE341Q38019745-3F14DEA3-9538-4DD6-AED9-B00360A5D51DQ38125212-059ECFFB-A9B6-46DB-A5BF-62C916FA5B2EQ38209914-C056C1AB-4BDE-4231-8154-6C3FB900947BQ38223276-9363A580-39B9-4747-B1C1-44F2EA76587FQ38223714-A714E53C-9285-49C9-996D-75E9AB9AF594Q38232366-85665FDB-140D-4C48-BA52-BC4CEF87605CQ38444551-8780D7A3-0B72-4B4E-B1D9-B12E789F0E69Q39147992-AF47BF75-70DC-4620-8C95-5A8A29554CE4Q41975077-098C445F-26A4-48BE-B869-82597849E141Q42792118-092B88C5-FA4F-4BFE-BF12-4921B3668A27Q48554462-54494AAF-C234-4439-8B66-D28C88151719Q50281040-99AE7C40-1A95-4F12-8CA9-21C99DA0DBC0Q57473376-CB43ACD2-1001-45B3-9C2E-74F49EE36B62Q58698161-3D5A6A76-02EC-467D-B91B-AC3BB270F041
P2860
Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@ast
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en-gb
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@nl
type
label
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@ast
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en-gb
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@nl
altLabel
Glutathione Precursor N-Acetyl ...... ized, Placebo-Controlled Trial
@en
prefLabel
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@ast
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en-gb
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@nl
P2093
P2860
P921
P3181
P1433
P1476
Glutathione precursor N-acetyl ...... ized, placebo-controlled trial
@en
P2093
Cristian Carmeli
Maria G Knyazeva
Michel Cuénod
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0029341
P407
P50
P577
2012-01-01T00:00:00Z